TrialBone marrow transplantation2021

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

R Pettengell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.